Analyst IMS Investment Management Services Ltd.
Position in GILD — Gilead Sciences, Inc.
CIK 1634208
Tel-aviv, L3
Position in GILD
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$213,893
-$22,060 QoQ
Shares Held
1,693
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1,887
of 2,266 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Analyst IMS Investment Management Services Ltd. holds $26,750,918 across 7 Drug Manufacturers - General names. GILD ranks #7 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NVO |
Novo Nordisk A S
|
410,770 | $19,692,313 | |
| 2 | LLY |
ELI LILLY & Co
|
2,047 | $2,455,233 | |
| 3 | JNJ |
Johnson & Johnson
|
8,024 | $2,037,854 | |
| 4 | MRK |
Merck & Co., Inc.
|
8,995 | $1,155,857 | |
| 5 | ABBV |
AbbVie Inc.
|
3,869 | $973,595 | |
| 6 | SNY |
Sanofi
|
5,208 | $222,173 | |
| 7 | GILD |
Gilead Sciences, Inc.
This page
|
1,693 | $213,893 |
All Filings in GILD
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $213,893 | 1,693 | Shares | Defined | 2026-07-29 | |
| 2026-03-31 | $235,953 | 1,693 | Shares | Defined | 2026-04-23 | |
| 2025-12-31 | $207,798 | 1,693 | Shares | Defined | 2026-01-20 | |
| No filing history on record for this holder in this stock. | ||||||